Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.098x

Based on the latest financial reports, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a cash flow conversion efficiency ratio of 0.098x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs246.75 Million ≈ $2.67 Million USD) by net assets (Rs2.53 Billion ≈ $27.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jagsonpal Pharmaceuticals Limited defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Jagsonpal Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Jagsonpal Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jagsonpal Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jagsonpal Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AeroSpace Technology of Korea KQ:067390	0.020x
Private Equity Holding AG SW:PEHN	0.010x
Bohae Brewery KO:000890	0.023x
msg life ag HM:MSGL	-0.019x
6K Additive Inc AU:6KA	-0.226x
Thong Guan Industries Bhd KLSE:7034	0.049x
GeoVision Inc TW:3356	-0.025x
cBrain A/S CO:CBRAIN	0.133x

Annual Cash Flow Conversion Efficiency for Jagsonpal Pharmaceuticals Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Jagsonpal Pharmaceuticals Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs2.40 Billion ≈ $25.95 Million	Rs553.00 Million ≈ $5.98 Million	0.230x	+22.82%
2024-03-31	Rs1.87 Billion ≈ $20.27 Million	Rs351.66 Million ≈ $3.80 Million	0.188x	-36.09%
2023-03-31	Rs1.59 Billion ≈ $17.18 Million	Rs466.54 Million ≈ $5.05 Million	0.294x	+586.35%
2022-03-31	Rs1.31 Billion ≈ $14.15 Million	Rs55.98 Million ≈ $605.41K	0.043x	-81.52%
2021-03-31	Rs1.22 Billion ≈ $13.19 Million	Rs282.22 Million ≈ $3.05 Million	0.231x	+128.51%
2020-03-31	Rs1.11 Billion ≈ $12.01 Million	Rs112.47 Million ≈ $1.22 Million	0.101x	-65.75%
2019-03-31	Rs1.04 Billion ≈ $11.30 Million	Rs308.98 Million ≈ $3.34 Million	0.296x	+1940.07%
2018-03-31	Rs980.47 Million ≈ $10.60 Million	Rs-15.76 Million ≈ $-170.43K	-0.016x	+45.50%
2017-03-31	Rs1.10 Billion ≈ $11.89 Million	Rs-32.41 Million ≈ $-350.56K	-0.029x	-132.09%
2016-03-31	Rs983.64 Million ≈ $10.64 Million	Rs90.39 Million ≈ $977.48K	0.092x	+104.01%
2015-03-31	Rs954.26 Million ≈ $10.32 Million	Rs42.98 Million ≈ $464.81K	0.045x	-40.94%
2014-03-31	Rs985.89 Million ≈ $10.66 Million	Rs75.18 Million ≈ $813.08K	0.076x	-37.74%
2013-03-31	Rs983.71 Million ≈ $10.64 Million	Rs120.50 Million ≈ $1.30 Million	0.122x	+70.29%
2012-03-31	Rs984.69 Million ≈ $10.65 Million	Rs70.83 Million ≈ $766.00K	0.072x	+3.52%
2011-03-31	Rs929.14 Million ≈ $10.05 Million	Rs64.56 Million ≈ $698.20K	0.069x	+611.50%
2010-03-31	Rs875.70 Million ≈ $9.47 Million	Rs8.55 Million ≈ $92.49K	0.010x	-95.61%
2009-03-31	Rs801.68 Million ≈ $8.67 Million	Rs178.16 Million ≈ $1.93 Million	0.222x	+198.39%
2008-03-31	Rs750.34 Million ≈ $8.11 Million	Rs55.88 Million ≈ $604.33K	0.074x	+127.99%
2007-03-31	Rs724.98 Million ≈ $7.84 Million	Rs23.68 Million ≈ $256.11K	0.033x	+44.65%
2006-03-31	Rs702.35 Million ≈ $7.60 Million	Rs15.86 Million ≈ $171.53K	0.023x	--

About Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$152.32 Million

Rs14.08 Billion INR

Market Cap Rank

#17687 Global

#925 in India

Share Price

Rs210.56

Change (1 day)

+0.65%

52-Week Range

Rs161.07 - Rs292.75

All Time High

Rs761.20